Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)
Others
Ratios

Relay Therapeutics (RLAY) Profit After Tax: 2019-2024

Historic Profit After Tax for Relay Therapeutics (RLAY) over the last 6 years, with Dec 2024 value amounting to -$337.7 million.

  • Relay Therapeutics' Profit After Tax rose 15.84% to -$74.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$297.6 million, marking a year-over-year increase of 13.79%. This contributed to the annual value of -$337.7 million for FY2024, which is 1.25% up from last year.
  • Latest data reveals that Relay Therapeutics reported Profit After Tax of -$337.7 million as of FY2024, which was up 1.25% from -$342.0 million recorded in FY2023.
  • Relay Therapeutics' Profit After Tax's 5-year high stood at -$52.4 million during FY2020, with a 5-year trough of -$363.9 million in FY2021.
  • In the last 3 years, Relay Therapeutics' Profit After Tax had a median value of -$337.7 million in 2024 and averaged -$323.4 million.
  • In the last 5 years, Relay Therapeutics' Profit After Tax surged by 30.40% in 2020 and then crashed by 594.25% in 2021.
  • Relay Therapeutics' Profit After Tax (Yearly) stood at -$52.4 million in 2020, then crashed by 594.25% to -$363.9 million in 2021, then rose by 20.16% to -$290.5 million in 2022, then decreased by 17.72% to -$342.0 million in 2023, then increased by 1.25% to -$337.7 million in 2024.